ACIP is the most frequent co-covered peer, appearing in 3 of the 12 tracked stories. Across a 222-day span, the pace is roughly 0.4 stories per week. The busiest single day carried 3. The clearest coverage concentration is regulation: 5 of 12 stories, with the rest divided among 4 other categories.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about American Academy of Pediatrics
ACIP is the most frequent co-covered peer, appearing in 3 of the 12 tracked stories. Across a 222-day span, the pace is roughly 0.4 stories per week. The busiest single day carried 3. The clearest coverage concentration is regulation: 5 of 12 stories, with the rest divided among 4 other categories. The tracked stories average 3.9 original sources each. 17% of these stories carry negative sentiment. American Academy of Pediatrics appears in 12 tracked Cross-Sector stories published from February 25, 2026 through October 4, 2026.
Stories tracked
12
Per week
0.4
Negative
17%
Sources per story
3.9
Computed from the 12 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering American Academy of Pediatrics. Shared-story counts are live from our verified record — not editorial picks.
A doctor coalition is pressing the NCAA and Big 12 to halt the Monster Energy sponsorship, citing the death of 16-year-old Davis Cripe and national data showing 23% of high school seniors consume energy drinks daily. For health professionals, this marks a shift from clinical advisories to direct policy intervention on adolescent caffeine exposure.
As countries like Australia impose strict social media bans for minors, new research is overturning the simplistic link between screen time and mental health, pushing pediatric guidance toward quality- and context-based recommendations.
More than 30 U.S. states have restricted cellphones in K–12 schools, forcing edtech providers to align with new research that prioritizes the quality of digital interactions over rigid time limits.
Biopharma companies face a potentially shrinking market and tougher FDA standards after Senate testimony highlighted 'very low certainty evidence' for pediatric gender treatments. With systematic reviews failing to show robust benefit, pipeline programs and commercial prospects for puberty blockers and cross-sex hormones are at risk.
Mass detention and deportation policies are driving a surge in stress-induced physical and mental health disorders among children aged 0 to 17. Healthcare providers warn of long-term developmental damage and a growing strain on pediatric clinical resources.
A Massachusetts federal judge has blocked the Trump administration's attempts to dismantle the standard U.S. vaccine schedule. The ruling halts Robert F. Kennedy Jr.’s efforts to reduce recommended pediatric immunizations, citing a failure to follow established scientific and procedural laws.
A federal judge in Massachusetts has issued a stay against the Department of Health and Human Services' sweeping changes to the national vaccine schedule. The ruling halts Secretary Robert F. Kennedy Jr.’s efforts to reduce recommended immunizations, finding the administration bypassed established scientific and legal protocols.
A federal judge in Massachusetts has issued a stay against the Trump administration's sweeping changes to the national vaccine schedule, ruling that the Department of Health and Human Services bypassed established scientific and legal procedures. The decision halts Secretary Robert F. Kennedy Jr.’s efforts to reduce recommended immunizations and suspends the activities of a newly reconstituted advisory panel.
Clinicians face significant challenges in distinguishing seasonal allergic rhinitis from common pediatric infections, though therapeutic protocols remain robust. This briefing examines the diagnostic complexities and the current landscape of pediatric allergy care.
A surge in parental demand for GLP-1 receptor agonists to treat autism-related symptoms is meeting stiff resistance from the medical community. While anecdotal reports suggest behavioral improvements, clinicians warn of significant safety risks and a lack of pediatric clinical data.
Emerging research challenges the long-held belief that smartphone usage is the primary cause of the adolescent sleep crisis. Instead, experts point to systemic factors like early school start times and academic pressure as the dominant drivers of record-low sleep duration.
New data reveals that United States childhood obesity rates have reached an all-time high, surpassing previous peaks and signaling a deepening public health crisis. The surge is prompting urgent calls for policy intervention, increased access to pediatric weight management technologies, and a reevaluation of nutritional standards.